Reduced serotonin type 1A receptor binding in panic disorder
- PMID: 14736842
- PMCID: PMC6729263
- DOI: 10.1523/JNEUROSCI.4921-03.2004
Reduced serotonin type 1A receptor binding in panic disorder
Abstract
Recent animal models suggest that disturbances in serotonin type-1A receptor (5-HT(1A)R) function may contribute to chronic anxiety, although it is not clear at all whether such models constitute relevant models for panic disorder (PD) in humans. The selective 5-HT(1A)R radioligand [18F]trans-4-fluoro-N-2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl]-N-(2-pyridyl)cyclohexanecarboxamide (FCWAY) permits in vivo assessment of central 5-HT(1A)R binding using positron emission tomography (PET). We studied 16 unmedicated symptomatic outpatients with PD and 15 matched healthy controls. Seven patients had an additional diagnosis of a current major depressive episode, however PD was the primary diagnosis. A 120 min PET study of 5-HT(1A)R binding was acquired using a GE Advance scanner in three-dimensional mode. Using quantitative PET image analysis, regional values were obtained for [18F]-FCWAY volume of distribution (DV), corrected for plasma protein binding, and K1, the delivery rate of [18F]-FCWAY from plasma to tissue. MRI scanning was performed using a GE Signa Scanner (3.0 Tesla) to provide an anatomical framework for image analysis and partial volume correction of PET data. PD patients showed lower DV in the anterior cingulate (t = 4.3; p < 0.001), posterior cingulate (t = 4.1; p < 0.001), and raphe (t = 3.1; p = 0.004). Comparing patients with PD, patients with PD and comorbid depression, and healthy controls revealed that DVs did not differ between PD patients and PD patients with comorbid depression, whereas both patient groups differed significantly from controls. These results provide for the first time in vivo evidence for the involvement of 5-HT(1A)Rs in the pathophysiology of PD.
Figures
References
-
- Bronen RA, Cheung G (1991) Relationship of hippocampus and amygdala to coronal MRI landmarks. Magn Reson Imaging 9: 449-457. - PubMed
-
- Carson RE, Lang L, Watabe H, Der MG, Adams HR, Jagoda E, Herscovitch P, Eckelman WC (2000) PET evaluation of [(18)F]FCWAY, an analog of the 5-HT(1A) receptor antagonist, WAY-100635. Nucl Med Biol 27: 493-497. - PubMed
-
- Charney DS, Drevets WC (2002) Neurobiological basis of anxiety disorders. In: Neuropsychopharmacology: the fifth generation of progress (Davis KL, Charney DS, Coyle JT, Nemeroff C, eds), pp 901-930. Philadelphia: Lippincott Williams and Wilkins.
-
- Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, Huang Y, Gautier C, Mathis C (1999) PET imaging of serotonin 1A receptor binding in depression. Biol Psychiatry 46: 1375-1387. - PubMed
-
- First MB, Gibbon M, Spitzer RL, Williams JBW (1996) Structured clinical interview for DSM-IV axis I disorders: nonpatient edition (SCID-I/NP). New York: Biometrics Department, New York State Psychiatric Institute.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical